Zobrazeno 1 - 10
of 70
pro vyhledávání: '"G.-V. Kornek"'
Autor:
B. Schuell, G. V. Kornek, D. Depisch, Werner Scheithauer, Fritz Lang, Bruno Schneeweiss, Thomas Gruenberger, N Dworan
Publikováno v:
British Journal of Cancer
To investigate whether a relationship between chemotherapy-associated adverse events and treatment efficacy exists, we have analysed the toxicity, objective response and survival data of 303 patients with advanced colorectal cancer. Patients were div
Autor:
M. Penz, F. Lang, D. Depisch, Werner Scheithauer, G. V. Kornek, B. Schuell, Thomas Gruenberger, K. Karall, F. Laengle
Publikováno v:
Annals of Oncology. 15:478-483
Background Patients with advanced biliary tract carcinoma face a particularly dismal prognosis, and no standard palliative chemotherapy has yet been defined. Among several different single agents, mitomycin C and, more recently, the oral fluoropyrimi
Autor:
B. Schüll, Markus Raderer, K. Schmid, G. V. Kornek, Werner Scheithauer, H. Huber, Friedrich Längle
Publikováno v:
Annals of Oncology. 13:1583-1589
Background: The aim of this phase I study was to determine the maximum-tolerated dose (MTD) and the dose-limiting toxicities (DLTs) of an intermittent weekly capecitabine regimen in combination with oxaliplatin. Furthermore, we intended to explore it
Autor:
B. Schüll, Markus Raderer, B. Schneeweiss, F. Lang, G. V. Kornek, D. Depisch, Wolfgang Fiebiger, Werner Scheithauer, A. Lenauer, Claudia Gedlicka
Publikováno v:
British Journal of Cancer
A phase II trial was performed to determine the antitumour efficacy and tolerance of combined paclitaxel and cisplatin with or without hematopoetic growth factor support in patients with advanced gastric cancer. Forty-five patients with histologicall
Autor:
G. V. Kornek, Claudia Gedlicka, Wolfgang Fiebiger, Irene Virgolini, T. Traub, A. Kurtaran, W. Scheithauer, Markus Raderer
Publikováno v:
Scandinavian Journal of Gastroenterology. 37:222-225
Carcinoma of the biliary system is a rare tumour entity, and patients with advanced disease face a dismal prognosis. Because of the absence of standard chemotherapy for advanced biliary carcinoma and reports of expression of receptors for somatostati
Autor:
Martin Pecherstorfer, Andreas Gleiss, Friedrich Laengle, Björn Jagdt, Matthias Unseld, Peter Krippl, Adelheid Seebacher, Jost Schwarzwald, Armin Gerger, Christoph Tinchon, Werner Scheithauer, Johannes Andel, Gerald W. Prager, Richard Greil, Svitlana Demyantes, Andreas Kretschmer, G. V. Kornek, Wolfgang Eisterer, Daniela Bianconi, Christoph C. Zielinski
Publikováno v:
Journal of Clinical Oncology. 35:604-604
604 Background: Bevacizumab-combined chemotherapy is well established in the induction treatment of metastatic colorectal cancer (mCRC). Despite tremendous efforts, no valid predictive marker for anti-VEGF treatment has so far been defined. CD87, the
Autor:
M. Penz, Markus Raderer, Julia Valencak, B. Dragosics, Andreas Chott, C. Österreicher, G. V. Kornek, Friedrich Vorbeck, Gerhard Hamilton, Michael Formanek
Publikováno v:
British Journal of Cancer
Lymphoma of the mucosa-associated lymphoid tissue (MALT) type usually arises in MALT acquired through chronic antigenic stimulation triggered by persistent infection and/or autoimmune processes. Due to specific ligand–receptor interactions between
Autor:
D. Hoelzer, R. Pasold, J. Ströhl, F.A. Hoffmann, Ch. Armbruster, S.B. Sobottka, N. Runkel, C. Stöllberger, A. Böhme, S. Grützner, W. Knauf, Helmut Oettle, Hanno Riess, T. Wiegel, M. Brandis, J. Behrens, M. Freund, H. Lassmann, G. Schackert, M. Burian, T. Kühn, H. Wolf, K. Guhr, A. Steinmetz, Ü. Aydemir, M.P. Wirth, K. Rossa, A.U. Schratter-Sehn, R. Kreienberg, A. Gerl, M. Herold, H.-J. Hurtz, Marjanka K. Schmidt, M. Huber, C. Neuchrist, C. Santjohanser, G.-V. Kornek, E. Hiller, W. Hinkelbein, A. Manseck, M. Alfrink, O. Hakenberg, N. Willich, W. Schmidt, J. Kornfehl, A. Franke, K. Koretz, U. Duffner, Chr. Klinkenstein, C. Rübe, Wolf O. Bechstein, S. Palkovic, S. Hahnfeld, S. Höcht, M. Aßmann, W. Wagner, R. Munker, L. Meyer, D. Huhn, D. Hölzel, C.M. Niemeyer, H. Eschenburg, M. Kirsch, J. Steglich, U. von Grünhagen
Publikováno v:
Oncology Research and Treatment. 23:89-94
Autor:
G. V. Kornek, A. Schratter-Sehn, Werner Kwasny, K. Haider, Gottfried J. Locker, Josef Karner, G. Krauss, D. Depisch, Werner Scheithauer, A Marczell
Publikováno v:
British Journal of Cancer
The aim of the study was to evaluate the effectiveness and safety of a combined treatment modality including systemic chemotherapy with 5-fluorouracil (FU), leucovorin, cisplatin and external beam radiotherapy in patients with locally advanced pancre
Publikováno v:
Oncology Research and Treatment. 23:177-182
SummaryIn head-and-neck cancer (HNC), cytotoxic chemotherapy traditionally was used for stage III/IV disease and for patients with metastatic or recurrent tumours. More recently, it has a